Olivier Danos
Chief Tech/Sci/R&D Officer at REGENXBIO INC.
Net worth: 460 826 $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Hüseyin Firat | M | - |
Profilomic SA
 Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France.
Firalis SA
 Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | 16 years |
| Karen Pignet-Aiach | F | 52 | 15 years | |
| Kenneth Mills | M | 49 | 16 years | |
| Frédéric Chéreau | M | 57 |
Horama SA
 Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | 3 years |
| Vit Vasista | M | 56 | 15 years | |
| Rodolphe Clerval | M | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | 4 years |
| Peter Lichtlen | M | 56 | 6 years | |
| Jean Bennett | M | 69 | 3 years | |
| Shiva G. Fritsch | F | - | 7 years | |
| Jennifer Zachary | F | 46 | 2 years | |
| Claudia Mitchell | M | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | 2 years |
| Allan Fox | M | 76 | 15 years | |
| Alexandra Glucksmann | M | 65 | 6 years | |
| Ram Palanki | M | 48 | 6 years | |
| George Migausky | M | 69 | 3 years | |
| Nicole Murphy | F | - | 9 years | |
| David Stump | M | 74 | 9 years | |
| Willem Broekaert | M | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Curran Simpson | M | 62 | 9 years | |
| Argeris Karabelas | M | 71 | 9 years | |
| Daniel Tassé | M | 64 | 8 years | |
| Anja Harmeier | M | - |
Corlieve Therapeutics SAS
 Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | - |
| Dana Fisher Cormack | M | - | 3 years | |
| Yvan Devaux | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Gilles Feutren | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Nicole Brument | F | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Patricia Françon | M | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | 3 years |
| Nicholas Barbet | M | - |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | - |
| Guillaume Blavier | M | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Bruno Montanari | M | 49 |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Bernard Daugeras | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Jean-Frédéric Chibret | M | 49 |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Florian Denis | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Laura Coruzzi | M | 71 | - | |
| Vanessa Malier | F | 51 |
Corlieve Therapeutics SAS
Corlieve Therapeutics SAS Pharmaceuticals: MajorHealth Technology Corlieve Therapeutics SAS provides neurology services. The company was founded by Richard Porter, Valerie Crepel and Christophe Mulle in November 2019 and is headquartered in Paris, France. | - |
| Thierry Laugel | M | 57 |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Philippe Peltier | M | 52 |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Béatrice Molac | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Patrick Christmas | M | 53 | 8 years | |
| Alain Goetzmann | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Philippe Monteyne | M | - |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | - |
| Franck Lescure | M | - |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Stephen Pakola | M | 55 | 5 years | |
| Sébastien Descarpentries | M | 50 |
Firalis SA
Firalis SA BiotechnologyHealth Technology Firalis SA engages in the discovery and development of biomarker-based diagnostics. It offers biomarkers for drug safety, cardiovascular, inflammatory and autoimmune diseases. The firm offers a portfolio of biomarker-based diagnostic methods and provides customer-tailored biomarker solutions. The company was founded on July 8, 2008 by Hüseyin Firat and is headquartered in Huningue, France. | - |
| Jerome W. Jackson | M | - | 9 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Annette Clancy | F | 70 | 5 years | |
| Michel Vounatsos | M | 62 | 6 years | |
| Daniel Abdun-Nabi | M | 69 | 6 years | |
| Sara Garon Berl | F | - | 8 years | |
| Tricia Truehart | F | - | 3 years | |
| Douglas Kerr | M | 57 | 2 years | |
| David S. Schilansky | M | 48 | 6 years | |
| Luke Beshar | M | 65 | 6 years | |
| George Scangos | M | 76 | 7 years | |
| Donald Hayden | M | 68 | 7 years | |
| Claudia Ordonez | M | 58 | 3 years | |
| Gisele Dion | F | 57 | 9 years | |
| Paul McKenzie | M | 58 | 3 years | |
| Andrea DiFabio | F | 55 | 11 years | |
| Richard Brudnick | M | 67 | 15 years | |
| Michael Cloonan | M | 53 | 14 years | |
| Aoife Brennan | M | 48 | 5 years | |
| Nithya Desikan | F | - | 1 years | |
| Ann Beasley | F | - | - | |
| Andrea DiMella | F | - | 3 years | |
| Scott Dreyer | M | 52 | 2 years | |
| Robyn Peters | F | - | 2 years | |
| Kelly Jackson | F | - | 4 years | |
| Vanya Sagar | F | 49 | 3 years | |
| Ritika Mahal | F | - | 3 years | |
| Paula Cobb | F | 51 | 13 years | |
| Adrian Gottschalk | M | 49 | 2 years | |
| C. Nichols | M | - | - | |
| Philip Ma | M | 59 | 2 years | |
| Kristen Stants | F | 51 | 3 years | |
| Joanne Viney | M | 58 | 5 years | |
| Diego Cadavid | M | 58 | 8 years | |
| Amit Rakhit | M | 54 | 5 years | |
| Benedikt Timmerman | M | 65 |
Horama SA
Horama SA BiotechnologyHealth Technology Horama SA engages in the development of gene therapies, It focuses on ophthalmological diseases for preserving visual autonomy of patients. The company was founded by Denis Cayet, Christian Hamel, Guylene Le Meur, Philippe Moullier, Vasiliki Kalatzis, and Michel Weberin March 2014 and is headquartered in Paris, France. | 2 years |
| Tony Kingsley | M | 60 | 6 years | |
| Raymond Pawlicki | M | 63 | 6 years | |
| Steven Holtzman | M | 70 | 5 years | |
| Kevin Koch | M | 63 | 2 years | |
| Douglas Williams | M | 66 | 4 years | |
| Adam Koppel | M | 54 | 2 years | |
| Ann Lenich Hards | M | - |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | 1 years |
| Robert A. Licht | M | - | - | |
| Jeffrey D. Bornstein | M | - | 3 years | |
| Spyridon Artavanis-Tsakonas | M | 77 | 5 years | |
| Sean O'Bryan | M | - | 2 years | |
| John Cox | M | 61 | 14 years | |
| Esther Alegria | M | 66 | 10 years | |
| A. Sanders | F | 60 | 6 years | |
| Sarah Ankri | F | - | - | |
| Fuat Firat | M | - |
Profilomic SA
Profilomic SA Medical/Nursing ServicesHealth Services Profilomic SA develops software solutions. It provides services in chemical, lipidomic and metabolomic analyses using liquid chromatography coupled to high resolution mass spectrometry. The company is headquartered in Boulogne-Billancourt, France. | - |
| Donald R. Johns | M | - | 2 years | |
| John F. Weidenbruch | M | 63 | 5 years | |
| Matthew P. Ottmer | M | 53 | 16 years | |
| Christopher Watt | M | 59 | 11 years | |
| Christian Schubert | M | - | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 68 | 68.00% |
| France | 32 | 32.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Olivier Danos
- Personal Network